trial summary · NCT07887971
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
BActinium-2: A Phase 1b, 2 Part, Multicenter, Open Label Study to Evaluate the Safety and Efficacy of Intravenous Administration of a B7-H3 Radiopharmaceutical ([225Ac]Ac AKY 2519) in Participants With B7-H3 Imaging Positive Solid Tumors
Trial record from the TrialBase DB dataset, status RECRUITING, condition NSCLC, sponsored by Aktis Oncology, Inc.. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This is a Phase 1b, 2-part, multi-center, open-label study to evaluate the safety, tolerability, dosimetry, and pharmacokinetics (PK) of \[64Cu\]Cu-AKY-2519 and/or \[225Ac\]Ac-AKY-2519, as well as the preliminary anti-tumor activity of \[225Ac\]Ac-AKY-2519 in participants with B7-H3 imaging positive solid tumors.
Source record: https://clinicaltrials.gov/study/NCT07887971
Facts
| registry id | NCT07887971 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | NSCLC |
| sponsor | Aktis Oncology, Inc. |
| sponsor class | INDUSTRY |
| enrollment | 152 |
| start date | 2026-11 |
| primary completion | 2028-12 |
| completion | 2033-12 |
| results posted | not reported |
Conditions
- NSCLC
- NSCLC (Advanced Non-small Cell Lung Cancer)
- ES-SCLC
- Small Cell Lung Cancer Extensive Stage
- B7H3
- Prostate Cancer
- HNSCC
- mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Head Neck Cancer Squamous Cell Metastatic
- ESCC or Esophageal Adenosquamous Carcinoma
- CRC
- CRC (Colorectal Cancer)
Interventions
- [225Ac]Ac-AKY-2519 (therapeutic)
- [64Cu]Cu-AKY-2519 (imaging)
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.